News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Acrux.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Acrux hits the spot with 27pc bump after FDA approves acne gel
Health & Biotech
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
Health & Biotech
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
News
Hot Money Monday: Momentum trading vs investing, and how both can profit using these 3 signals
News
ASX Small Caps and IPO Weekly Wrap: A short week for a small win on the ASX
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX slumps 1.3pc on rate jitters; gold miners higher as bullion hits record
Health & Biotech
ASX Health Stocks: Acrux jumps 70pc after launching its acne gel in the US
News
ASX Small Caps Lunch Wrap: Who’s sizing up the ultimate white elephant this week?
News
Top 10 at 10: Which gold miner made $125m profit last quarter?
News
ASX Small Caps Lunch Wrap: Anyone else feeling like they’ve heard this story somewhere before?
Health & Biotech
ASX Health Stocks: US FDA happy to review anal fissure drug; gives green light to Clarity’s Phase 3 trial
Health & Biotech
ASX Health Stocks: Polynovo surges on sales; Pacific Edge wiped out 60pc after losing Medicare coverage
Health & Biotech
ASX Health Stocks: Acrux and Lumos await potential approvals from the US FDA
Health & Biotech
ASX Health Stocks: Antisense says ATL1102 could be effective in rare genetic muscle disease
Health & Biotech
Check Up: ASX biotech comes alive as health stocks tackle international markets
Health & Biotech
